Can You Quantify the ROI of Modern Clinical Data Management? Yes. Here’s How.

A decade ago, an average Phase III study collected roughly one million data points. Today, that same late-phase study involves approximately 3.5 million data points, and the number continues to climb. To manage that growth, organizations have layered on tools for aggregation, reporting, reconciliation, and review. The result: a fragmented ecosystem where critical processes are still manual, cycle times stretch longer than they should, and lean teams continue to feel the strain. As new technologies come along, teams are not only asking: What does this tech do? They’re also asking: Is this tech worth the investment?  

That’s exactly the question Hobson & Company, a research firm specializing in ROI studies, set out to answer. Through in-depth interviews with eClinical Solutions clients, Hobson validated the key sources of operational and financial value delivered by a unified, AI-powered clinical data intelligence platform. Below, we explore their findings, outlined in the white paper, Driving ROI: The Business Case for a Comprehensive Clinical Data and Analytics Solution.  

Turning Complexity Into Measurable Value 

In examining the business impact of the elluminate® Clinical Data Intelligence Platform—which unites data ingestion, transformation, and analytics into one cohesive platform—Hobson & Company found that a unified data platform drove measurable improvements across three core areas: 

• Modernizing data infrastructure and analytics 
• Streamlining clinical and data operations 
• Improving speed and quality of clinical trials 

Sponsors and CROs using elluminate reported substantial reductions in time spent aggregating data from disparate systems, creating new reports and listings, reviewing medical and clinical data, managing queries, and overseeing trial progress.  

Hobson notes that, in some cases, organizations reduced the number of maintained systems by 65%. Others saw a 40% reduction in time from last patient last visit (LPLV) to database lock. Medical monitors reported saving 50–65% of the time previously spent reviewing safety data. 

What the Numbers Show 

Using validated customer inputs, Hobson built a value calculator to model potential ROI. For a sample organization with: 

• 40 active studies per year 
• 8 hours per study per week spent on data aggregation 
• 20 hours per study per month spent gathering data for oversight 
• 6 weeks from LPLV to database lock 

A three-year investment of $5.0M in elluminate generated: 

• $17.2M in total value creation 
• 241% return on investment 
• Positive cash flow in just 4.6 months 

While actual results vary by organization, the research confirms what many study teams already suspect: Fragmented data environments create hidden costs, and a modern integrated platform can unlock significant operational and financial value. 

You can read Driving ROI: The Business Case for a Comprehensive Clinical Data and Analytics Solution here.

How to Discover Your Potential ROI 

Every organization’s starting point is different. That’s why Hobson & Company developed an interactive value calculator to help sponsors and CROs model their own inputs and quantify potential returns. 

If you’re wondering whether modernizing your clinical data infrastructure is worth it, there’s now a way to find out.

Try the elluminate value calculator and see what value you could unlock.